Search by property

This page provides a simple browsing interface for finding entities described by a property and a named value. Other available search interfaces include the page property search, and the ask query builder.

List of results

• Dos Santos Martins (2016): Placebo-Controlled, Double-Blind, Randomized Study of a Dry Guarana Extract in Patients with Head and Neck Tumors Undergoing Chemoradiotherapy: Effects on Fatigue and Quality of Life  + (NI)
• Yekta et al. (2012): Ginger as a miracle against chemotherapy-induced vomiting  + (NI)
• Sun et al. (2016): A prospective study to evaluate the efficacy and safety of oral acetyl-L-carnitine for the treatment of chemotherapy-induced peripheral neuropathy  + (NI)
• Lin et al. (2010): Discrepancy of the effects of zinc supplementation on the prevention of radiotherapy-induced mucositis between patients with nasopharyngeal carcinoma and those with oral cancers: subgroup analysis of a double-blind, randomized study  + (Nasopharyngeal cancer: intervention arm: mean (SD): 50.60 (14.17) Nasopharyngeal cancer: placebo arm: mean (SD): 52.63 (11.28) Oral cancer: intervention arm: mean (SD): 50.48 (9.10) Oral cancer: placebo arm: mean (SD): 51.30 (10.81))
• Chung et al. (2016): Randomized Trial of Vitamin C/E Complex for Prevention of Radiation- Induced Xerostomia in Patients with Head and Neck Cancer  + (Overall age in years, mean (SD) = 58.8 (10.5); per arm: - intervention: 56.6 (11.3) - placebo: 61.6 (9.6))
• Rostock et al. (2013): Chemotherapy-Induced Peripheral Neuropathy in Cancer Patients: A Four-Arm Randomized Trial on the Effectiveness of Electroacupuncture  + (Overall mean (SD): 52.7 (10.0) years; per arm: - electroacupuncture arm: 49.9 (9.6) - hydroelectric bath arm: 52.3 (11.3) - vit. B arm: 56.3 (11.1) - placebo arm: 52.0 (8.1))
• Konmun et al. (2017): A phase II randomized double-blind placebo-controlled study of 6-gingerol as an anti-emetic in solid tumor patients receiving moderately to highly emetogenic chemotherapy  + (Overall median (range) in years: 53 (19-81); per arm: - intervention arm: 52 (19-81) - placebo arm: 55 (37-79))
• Fallon et al. (2017) II: Sativex oromucosal spray as adjunctive therapy in advanced cancer patients with chronic pain unalleviated by optimized opioid therapy: two double-blind, randomized, placebo-controlled phase 3 studies  + (Part A Mean (SD) age: 61.2 (11.2) years Part B Mean (SD) age per arm: Sativex = 61.4 (10.9) years Placebo = 61.6 (11.8) years)
• Mayne et al. (2001): Randomized Trial of Supplemental beta-Carotene to Prevent Second Head and Neck Cancer  + (Per group mean (SD) - intervention: 67.8 (9.8) - placebo: 67.9 (9.3))

• Dias et al. (2015): The chemopreventive effect of Ginkgo biloba extract 761 against cisplatin ototoxicity: a pilot study  + (Range 24–69 years)

• Sharp et al. (2010): A randomised, controlled trial of the psychological effects of reflexology in early breast cancer  + (Range 32-81 years; Mean 58.78 years (SD:10.31))
• Campos et al. (2011): Guarana (Paullinia cupana) Improves Fatigue in Breast Cancer Patients Undergoing Systemic Chemotherapy  + (Range: 22-70 years)
• Walsh et al. (2010): Use of alpha,25-dihydroxyvitamin D3 treatment to stimulate immune infiltration into head and neck squamous cell carcinoma  + (Range: 45-92 Intervention arm: mean: 66 Control arm: mean: 63)
• Howells et al. (2011): Phase I randomised double-blind pilot study of micronized resveratrol (SRT501) in patients with hepatic metastases - safety, pharmacokinetics and pharmacodynamics  + (SRT501 (resveratrol): 68.5(10.8) years Placebo: 64.3(6.35) years)
• Muecke et al. (2014): Multicenter, phase 3 trial comparing selenium supplementation with observation in gynecologic radiation oncology: follow-up analysis of the survival data 6 years after cessation of randomization  + (Start of the original study (Muecke et al., 2010): mean (SD); range: 64.3 (10.1); 31–80 years)
• Keshavarzi et al. (2019): The effect of vitamin D and E vaginal suppositories on tamoxifen-induced vaginal atrophy in women with breast cancer  + (Vitamin D arm: mean (SD): 43.7 (3.9) vitamin E arm: mean (SD): 44.1 (4.6) placebo arm: mean (SD): 42.0 (6.3))
• Sanaati et al. (2016): Effect of Ginger and Chamomile on Nausea and Vomiting Caused by Chemotherapy in Iranian Women with Breast Cancer  + (n in the following age groups for ginger vs. chamomile vs. control: - 20-30 years: 1/1/1 - 31-40 years: 6/1/6 - 41-50 years: 7/12/7 - 51-60 years: 1/1/1 Range: 20-60 years)
• Kottschade et al. (2011): The use of vitamin E for the prevention of chemotherapy-induced peripheral neuropathy: results of a randomized phase 3 clinical trial  + (≤ 50 years: 39%, > 50 years: 61%)